Navigation Links
Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO
Date:7/1/2009

s helped the nation's most influential hospitals, health care systems and government agencies prioritize and invest in technologies that make health care safer and more affordable," said Coye. "It has become increasingly clear that our industry-leading research must become more widely accessible as the nation seeks to transform health care and leverage emerging clinical and health information technologies to do so. Our vision has always been to advance the use of new technologies to improve the health of people and communities. Affiliating with PHI is the best way to assure fulfillment of our vision."

HealthTech and PHI are currently exploring the best way to archive and disseminate HealthTech's work in order to make it widely available to researchers, public health leaders, policy leaders and health providers both in the U.S. and globally.

"HealthTech's impressive body of work complements our mission to advance community health and improve the efficacy of public health statewide, nationally and internationally," said Mary A. Pittman, DrPH, president and CEO of PHI. "We are thrilled to be in a position to extend the influence of HealthTech's important work and to leverage its assets to ensure that public health is included in the dialog on health reform."

Coye has extensive experience in both the public and private sectors. She served as Commissioner of Health for the State of New Jersey and Director of the California Department of Health Services, in addition to heading the Division of Public Health at the Johns Hopkins School of Hygiene and Public Health, leading marketing and product development for interactive health communication and disease management at HealthDesk Corp, serving as Executive Vice President for the Good Samaritan Health System, and directing The Lewin Group's West Coast office.

As a member of the Institute of Medicine, Coye co-authored the reports To Err is Human and
'/>"/>

SOURCE CalRHIO
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia
2. Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June
3. Medeguide Founder to Lead Online Healthcare Marketing Workshop at the Healthcare Travel Conference in Singapore
4. Founder of Snoring Isn't Sexy, LLC Addresses Annual Meeting of the American Academy of Dental Sleep Medicine
5. Helping Dad Stay Independent: The Best Fathers Day Gift for an Aging Parent - A Checklist from Dr. Dan Tobin, Founder and CEO of Care Support of America
6. GECKO Founder to Race 135 Miles Across Death Valley in the Badwater Ultramarathon to Raise Funds and Awareness for New Nonprofit Dedicated to Helping Kids Get Outdoors
7. Principle Pharmacy Group, Inc. Announces Founders Retirement, New CEO, Officers and Appointments to Its Board of Directors
8. Network Merchants, Inc (NMI) Founders Donate $50,000 to Schaumburgs Childrens Home & Aid
9. Founder of Snoring Isn't Sexy, LLC Urges All Dentists to Screen Their Patients for Snoring and Obstructive Sleep Apnea
10. Kay Renz PR to Workout Publicity Routine for Adriana Martin, Founder of Fit Mom For Life
11. Plane Crash Claims Arcadians Chairman and Founder, John H. Austin M.D.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... World Volunteer Computing Team has joined the QMC...nte Carlo method to problems in Quantum Chemistry.... life science research. This project joins Folding...(gravity wave detection), and GPUGrid (molecular ... (PRWEB) November 24, 2009 -- GeoPen...
(Date:11/24/2009)... Launches EyeCentral Remote Video Platform for the...evenue for Central Stations and Security Dealers. ...ovember 24, 2009 -- NCL Security Launches EyeCentr... to Generate Recurring Monthly Revenue for Central...ed security systems has been and still is a great ...
(Date:11/23/2009)... -- A team of researchers at the University of Cal...eloped a way to simulate blood flow on the compute... a new tool that may help surgeons plan for a life...ch is performed on babies born with severe congeni...nt their work next week at the 62nd Annual Meeting...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)... Testing now provides super-private STD testing. T... Chlamydia, Herpes, HIV, Gonorrhea, Hepatitis, Syp... (PRWEB) November 23, 2009 -- Same...samedaystdtesting.com is a company that offers co...ailable to accurately and anonymously test for man...
Breaking Medicine News(10 mins):Health News:GeoPense Announces it has Joined QMC@home Project 2Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2Health News:New tool for helping pediatric heart surgery 2Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2
...he Australian government has recently started, ads...and stay fit, instead off being a couch potato all...hildren fail to recognize that their children are ...saying that they are similar to their das or broth...
...nder General Medical Council code of practice, whi...rovide information to patients// who request abort...f the Congregation for the Doctrine of the Faith a...the corner. With these codes as a base a Cath...
...he state governed medical colleges have not much t...dical Council of India (MCI) //, which has given t...s or face a risk of de-affiliation. MCI is t...s, which is due to end in May. A month has ...
...he "abortion pill" RU-486 has claimed two more liv... that brought renewed calls for pulling the drug c...also called Mifeprex or mifepristone, has not been...y implicated in four deaths of women who had taken...
...ccording to the Nurse's Health Study of the Harvar... in women can be prevented by doing regular exerci...e study was based on a survey of 90,000 women, who...imming. Women with a BMI between 18.5 and 24...
...onths after the destructive visit off Hurricane Ka...fects of the fury unleashed on the survivors scatt...o large the loss so dear that the people are now f...ng program in American history. Sources place...
Other Medicine News:Health News:Catholic Church and Abortion. 2Health News:Hurricane Hangover: Katrina Still Haunts 2Health News:Hurricane Hangover: Katrina Still Haunts 3Health News:Hurricane Hangover: Katrina Still Haunts 4
(Date:11/23/2009)...3/PRNewswire/--TwooftheChicagoarea,sleadingBoardCe...inwomen,sbreastimaging,couplingthelatesttechnology...soundwiththeabilitytohavethefullrangeofdigitalimag...foresheleavestheoffice.Drs.AhmedFaragandJoanWerber...hecurrent6-9monthwaitforanappointmentcommonlyfound...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...hiefExecutiveOfficer,andMichaelJ.Lambert,Executive...topresentatthe21stAnnualPiperJaffrayHealthCareConf...day,December2,2009,at10:00a.m.ET.Mr.LukianovandMr....
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq:...t-reagentsystemstothebloodtransfusionindustry,toda...fray21stAnnualHealthCareConferenceinNewYork,NYwill...Company,spresentationisscheduledforTuesday,Decembe...tionwillbeavailablethroughthe"AboutUs--InvestorInf...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 32009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 12009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 1Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 2
... Program for Oral Compounds,to Treat Alcohol Depe...2, 2007--Alkermes, Inc.,(Nasdaq: ALKS) today annou...trial of ALKS 29 in alcohol dependent patients. Ba...rward with its,development program for oral produc...is a combination of two agents with distinct,pharm...
...07 -- DOR BioPharma, Inc.,(OTCBB: DORB) ("DOR" or ...lts from testing of a multivalent form of its botu...lished in the journal,Infection and Immunity (Ravi...75, p. 3043 ). These results are the first that,de...valent vaccine,that is active by the mucosal route...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: